Last year, Pfizer (NYSE: PFE) had reason to celebrate when a court ruled in favor of its patent on Viagra. This extended the company’s monopoly on the drug through 2019.
Well, thanks to a few researchers in Argentina, Pfizer may have just received a new reason to pop open the champagne.
A recent study at the National University of Quilmes found that Viagra fixes something else men around the world struggle with – jet lag. Seriously.
Scientists pumped lab mice with a small dose of sildenafil (the active ingredient in Viagra) – and voila! The mice recovered from the shock of radical time zone changes twice as fast as mice without the drug.
How can this be possible?
Simply put, sildenafil slows the breakdown of a regulator in the bloodstream that advances our internal clock.
Keep in mind, the study’s only proven sildenafil’s ability to reduce jet lag in mice. However, based on messages the scientists have received after they published their research, its ability to work on humans already looks promising…
As Dr. Diego Golombek, a professor at the university, says, “People who take Viagra for different reasons told us after the publication that it effectively modified, beneficially, the sleep cycle (the alterations of biological rhythms) if they fly.”
Better yet, unlike the more popular use for Viagra, women can take it to reduce jet lag, too!
Granted, “Viagra and other erectile dysfunction drugs are not being recommended by their manufacturers as a treatment for jet lag,” as Reuters’ Elly Park reports. But if the researchers can prove its efficacy with humans as the study continues, Pfizer should certainly look into this new potential revenue stream while its patents on Viagra last.